£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. Lipodystrophy is a side-effect of some anti-HIV drugs. These are mainly ...

AIDS Rev. 2008;10(3):152-161. In patients with HIV-related lipodystrophy (assessed by patients and confirmed by physicians), Marin, et al. have recently validated a new questionnaire consisting of ...

Thirty-one HIV-infected individuals (median age 48 years, 97% male) with facial lipoatrophy (based on physician assessment) have been randomly assigned to immediate (weeks 0 and 6) or delayed ...

The findings reported by the researchers answer some of the questions as to why patients receiving successful treatment for HIV end up with abnormal fat loss and deposits – a problem call ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve ...

F8 formulation intended to replace EGRIFTA SV ® with simplified dosing for the treatment of excess abdominal fat in adults with HIV and lipodystrophy MONTREAL, Nov. 26, 2024 (GLOBE NEWSWIRE) — ...